Exane Derivatives’s Adtran ADTN Stock Holding History

Exane Derivatives’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$175	Sell	10 -256	-96%	-$4.63K	﹤0.01%	682
2022 Q1	$4.91K	Sell	266 -13,961	-98%	-$276K	﹤0.01%	699
2021 Q4	$325K	Sell	14,227 -415	-3%	-$8.4K	0.08%	253
2021 Q3	$275K	Buy	14,642 +2,343	+19%	+$49.3K	0.07%	310
2021 Q2	$236K	Buy	+12,299	New	+$238K	0.05%	355

Other funds holding ADTN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Exane Derivatives's ADTN Position: Q2 2022 in Review

Exane Derivatives reduced its Adtran (ADTN) stake by 96% in Q2 2022, selling an estimated $4.63K and leaving 10 shares worth $175. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Exane Derivatives first reported a position in ADTN in Q2 2021 and has held it in 5 quarters since. The position peaked at $325K in Q4 2021. 162 funds tracked by Wall St. Rank hold ADTN as of Q2 2022.

Exane Derivatives held 10 shares of Adtran worth $175 as of Q2 2022.
Exane Derivatives sold 256 Adtran shares in Q2 2022, an estimated $4.63K.
Adtran made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #682 holding.
Exane Derivatives first reported a position in Adtran in Q2 2021 and has held it in 5 quarters since.
Exane Derivatives's Adtran position peaked at $325K in Q4 2021.
162 funds tracked by Wall St. Rank held Adtran as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.